Literature DB >> 12199815

Change in serum procalcitonin (deltaPCT) predicts the clinical outcome of children admitted with febrile neutropenia.

Chris Barnes, Vera Ignjatovic, Fiona Newall, John Carlin, Felicia Ng, Simone Hamilton, David Ashley, Keith Waters, Paul Monagle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12199815     DOI： 10.1046/j.1365-2141.2002.37029.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies.

Authors:  M von Lilienfeld-Toal; A Schneider; K Orlopp; C Hahn-Ast; A Glasmacher; F Stüber
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.603

2.  Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.

Authors:  Nicolas Penel; Charles Fournier; Stéphanie Clisant; Michèle N'Guyen
Journal:  Support Care Cancer       Date:  2004-02-10       Impact factor: 3.603

3.  Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults.

Authors:  Karin S R Massaro; Silvia F Costa; Claudio Leone; Dalton A F Chamone
Journal:  BMC Infect Dis       Date:  2007-11-22       Impact factor: 3.090

4.  Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia.

Authors:  Victoria Hemming; Adam D Jakes; Geoff Shenton; Bob Phillips
Journal:  BMC Pediatr       Date:  2017-01-05       Impact factor: 2.125
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.